One more stock to consider today is Novavax (NVAX), a clinical-stage biopharmaceutical company focused on creating differentiated, value- upon current preventive options for a range of infectious diseases. Insiders are buying this stock into strength, since shares are up 15% during the last three months.
Novavax has a market cap of $278 million and an enterprise value of $250 million. This stock trades at a premium valuation, with a price-to-sales of 12.55 and a price-to-book of 4.51. Its estimated growth rate for this year is 8.7%, and for next year it's pegged at 19%. This is a cash-rich company, since the total cash position on its balance sheet is $28.41 million and its total debt is just $1.26 million.>>5 Stocks Under $5 to Watch A director just bought 100,000 shares, or $203,000 worth of stock, at $2.03 per share. From a technical perspective, NVAX is currently trending above both its 50-day and 200-day moving averages, which is bullish. This stock recently surged higher back above both of those key moving averages with heavy upside volume. That move pushed shares of NVAX into breakout territory above $1.85 to $1.94 a share, and it's now quickly moving the stock within range of triggering another near-term breakout trade. If you're bullish on NVAX, then look for long-biased as long as it's trending above its 50-day at $1.90, and then once it breaks out above some near-term overhead resistance at $2.11 a share with high volume. Look for a sustained move or close above $2.11 a share with volume that registers near or above its three-month average action of 741,297 shares. If that breakout hits soon, then NVAX will set up to re-test or possibly take out its next major overhead resistance levels at $2.28 to $2.40 a share. Any high-volume move above $2.40 to $2.44 will then put $2.60 to $3 into range for shares of NVAX. To see more stocks with notable insider buying, check out the Stocks With Big Insider Buying portfolio on Stockpickr. -- Written by Roberto Pedone in Winderemere, Fla.
Twitter and become a fan on Facebook.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV